HealthCare Global EnterprisesNSE:HCG +2.10%85 Return-on-Tangible-Equity is 0.95% as of Mar. 2026, which is 81% below its 10-year median of 4.91. GuruFocus rates NSE:HCG with a GF Score™ of 85/100 and a GF Value™ of ₹579.47 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 579 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 69.26% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. HealthCare Global Enterprises's annualized net income for the quarter that ended in Mar. 2026 was ₹87 Mil. HealthCare Global Enterprises's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹9,115 Mil. Therefore, HealthCare Global Enterprises's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 0.95%.
The historical rank and industry rank for HealthCare Global Enterprises's Return-on-Tangible-Equity or its related term are showing as below:
NSE:HCG'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -47.23 Med: 4.91 Max: 9.03
Current: 2.31
During the past 12 years, HealthCare Global Enterprises's highest Return-on-Tangible-Equity was 9.03%. The lowest was -47.23%. And the median was 4.91%.
NSE:HCG's Return-on-Tangible-Equity is ranked worse than 69.26% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.21
vs NSE:HCG: 2.31
HealthCare Global Enterprises (NSE:HCG) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
HealthCare Global Enterprises Return-on-Tangible-Equity Related Terms
HealthCare Global Enterprises Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises Return-on-Tangible-Equity Chart
NSE:HCG vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.95% mean?
HealthCare Global Enterprises (NSE:HCG) has a Return-on-Tangible-Equity of 0.95% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on HealthCare Global Enterprises and its competitors. This is 81% below median its historical median of 4.91. According to the industry distribution chart, HealthCare Global Enterprises ranks #401 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 69.3%.
Is HealthCare Global Enterprises' Return-on-Tangible-Equity too high?
HealthCare Global Enterprises' current Return-on-Tangible-Equity of 0.95% is 81% below median its 10-year median of 4.91. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.21. HealthCare Global Enterprises' value of 0.95% is 90.7% below this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #401 out of 579 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #401 out of 579 companies for Return-on-Tangible-Equity. This places HealthCare Global Enterprises in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.21. HealthCare Global Enterprises' value of 0.95% is 90.7% below this benchmark. While the company's 10-year median is 4.91 vs. the industry median of 10.21, HealthCare Global Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.21, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Return-on-Tangible-Equity of 0.95% is 90.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Return-on-Tangible-Equity is 0.95%, which is 81% below median its own 10-year median of 4.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹579.47, compared to a current price of ₹666.40 — trading 15% above its estimated fair value. The current Return-on-Tangible-Equity is 0.95%, which is 81% below median its 10-year median of 4.91 and 90.7% below the Healthcare Providers & Services industry median of 10.21. HealthCare Global Enterprises' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Return-on-Tangible-Equity is 0.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹666.40 is trading 15% above its estimated GF Value™ of ₹579.47.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
Return-on-Tangible-Equity: 0.95% (81% below median its 10-year median of 4.91)
GF Value™: ₹579.47 vs. price of ₹666.40 (15% above fair value)
Industry Position: 90.7% below the Healthcare Providers & Services median (#401 of 579)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
85GF Score
Get the complete analysis for NSE:HCG
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
